Newswire April 2, 2025
Survey shows executives turning to automation, AI, and domestic production amid geopolitical and regulatory shifts
TAMPA, Fla., April 2, 2025 (Newswire.com) – A Q1 2025 ad hoc survey conducted by Black Book Research of 60 pharmaceutical and biotech manufacturing executives – half based in the U.S. and half operating offshore – reveals mounting momentum for reshoring U.S. healthcare manufacturing. The findings point to tariff-driven incentives, automation adoption, and supply chain vulnerabilities as central catalysts prompting a strategic shift in sourcing strategies across pharmaceuticals, diagnostics, and medical supplies.
The data highlights the economic and regulatory realities of rebuilding domestic production capacity in a highly automated, post-pandemic landscape.
Prompted by actual and anticipated tariffs, federal incentives, and ongoing geopolitical uncertainty, U.S. industry...
Today's Sponsors
Today's Sponsor